IOLCP — IOL Chemicals and Pharmaceuticals Share Price
- IN₹19.23bn
- IN₹18.92bn
- IN₹21.33bn
- 94
- 46
- 49
- 72
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 10.94 | ||
PEG Ratio (f) | 0.48 | ||
EPS Growth (f) | 29.61% | ||
Dividend Yield (f) | 2.27% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.17 | ||
Price to Tang. Book | 1.18 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.94 | ||
EV to EBITDA | 10.04 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.87% | ||
Return on Equity | 5.99% | ||
Operating Margin | 5.8% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 18,944.7 | 19,669.8 | 21,840.2 | 22,171.1 | 21,327.9 | 22,547.5 | 24,771 | 4.82% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +50.81 | +20.03 | -60.03 | -21.97 | -3.67 | +1.73 | +29.61 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical, and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) include Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin. Its Specialty Chemical division includes Ethyl Acetate, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and paint industry.
Directors
- Rajender Malla CHM (65)
- Sanjay Chaturvedi CEO
- Pardeep Khanna CFO
- Krishan Singla CCO
- Abhay Singh CCO
- Vikas Gupta EDR
- Kushal Rana EDR
- Sandhya Mehta IND
- Harpal Singh IND (63)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 29th, 1986
- Public Since
- November 5th, 2010
- No. of Shareholders
- 130,003
- No. of Employees
- 2,777
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 293,527,510

- Address
- 85, Industrial Area, `A',, LUDHIANA, 141003
- Web
- https://www.iolcp.com/
- Phone
- +91 1612225531
- Contact
- Abhay Singh
- Auditors
- Ashwani & Associates
Upcoming Events for IOLCP
Q1 2026 IOL Chemicals and Pharmaceuticals Ltd Earnings Release
IOL Chemicals and Pharmaceuticals Ltd Annual Shareholders Meeting
Similar to IOLCP
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 21:23 UTC, shares in IOL Chemicals and Pharmaceuticals are trading at IN₹66.08. This share price information is delayed by 15 minutes.
Shares in IOL Chemicals and Pharmaceuticals last closed at IN₹66.08 and the price had moved by -17.47% over the past 365 days. In terms of relative price strength the IOL Chemicals and Pharmaceuticals share price has underperformed the S&P BSE 100 Index by -22.26% over the past year.
The overall consensus recommendation for IOL Chemicals and Pharmaceuticals is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe IOL Chemicals and Pharmaceuticals dividend yield is 1.21% based on the trailing twelve month period.
Last year, IOL Chemicals and Pharmaceuticals paid a total dividend of IN₹0.80, and it currently has a trailing dividend yield of 1.21%. We do not have any data on when IOL Chemicals and Pharmaceuticals is to next pay dividends.
We do not have data on when IOL Chemicals and Pharmaceuticals is to next pay dividends. The historic dividend yield on IOL Chemicals and Pharmaceuticals shares is currently 1.21%.
To buy shares in IOL Chemicals and Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹66.08, shares in IOL Chemicals and Pharmaceuticals had a market capitalisation of IN₹19.23bn.
Here are the trading details for IOL Chemicals and Pharmaceuticals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: IOLCP
Based on an overall assessment of its quality, value and momentum IOL Chemicals and Pharmaceuticals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in IOL Chemicals and Pharmaceuticals is IN₹87.56. That is 32.5% above the last closing price of IN₹66.08.
Analysts covering IOL Chemicals and Pharmaceuticals currently have a consensus Earnings Per Share (EPS) forecast of IN₹4.66 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like IOL Chemicals and Pharmaceuticals. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -10.62%.
As of the last closing price of IN₹66.08, shares in IOL Chemicals and Pharmaceuticals were trading -16.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The IOL Chemicals and Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is 10.94. The shares last closed at IN₹66.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
IOL Chemicals and Pharmaceuticals' management team is headed by:
- Rajender Malla - CHM
- Sanjay Chaturvedi - CEO
- Pardeep Khanna - CFO
- Krishan Singla - CCO
- Abhay Singh - CCO
- Vikas Gupta - EDR
- Kushal Rana - EDR
- Sandhya Mehta - IND
- Harpal Singh - IND